Cont from replied post: they could have settled for $30m in advance and been better off... Intev demonstrates confidence. And recently had an injection. One would assume the "Intev funding committee" holds a card.
--- Like wise Cvm has shown their commitment. The repeated funding The simple fact arbitration is still a discussion. Somebody has a stake worth protecting.
----
Limits: I don't know....but I think: An offering during and through the duration of the current arbitration is zero. Am offering during a FDA hold is not happening.
An r/s could; but that meeting needs to be announced soon....if it is to be so that is...???
----
So. It's an songwriting type predicament that we are seeing It's also that purity that leads me to believe that no offering is coming. Caveat is with no offering a buyout is imminent (unless some precious goals were met???)
the data is imminent from those 2013 Intev enrollees....
News 
Market Data 
Discover 
AI
